Raymond James Trust’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $682K | Sell |
10,176
-16,602
| -62% | -$1.11M | 0.01% | 643 |
|
|
2024
Q2 | $3.04M | Buy |
26,778
+1,028
| +4% | +$117K | 0.07% | 229 |
|
|
2024
Q1 | $3.57M | Buy |
25,750
+3,651
| +17% | +$506K | 0.09% | 212 |
|
|
2023
Q4 | $2.74M | Buy |
22,099
+17,002
| +334% | +$2.11M | 0.07% | 238 |
|
|
2023
Q3 | $476K | Sell |
5,097
-764
| -13% | -$71.3K | 0.01% | 663 |
|
|
2023
Q2 | $753K | Buy |
5,861
+1,221
| +26% | +$157K | 0.02% | 500 |
|
|
2023
Q1 | $539K | Sell |
4,640
-318
| -6% | -$36.9K | 0.02% | 601 |
|
|
2022
Q4 | $562K | Sell |
4,958
-619
| -11% | -$70.2K | 0.02% | 556 |
|
|
2022
Q3 | $449K | Sell |
5,577
-250
| -4% | -$20.1K | 0.02% | 617 |
|
|
2022
Q2 | $435K | Sell |
5,827
-3,105
| -35% | -$232K | 0.02% | 634 |
|
|
2022
Q1 | $1.14M | Buy |
8,932
+268
| +3% | +$34.3K | 0.04% | 378 |
|
|
2021
Q4 | $1.16M | Sell |
8,664
-204
| -2% | -$27.4K | 0.03% | 388 |
|
|
2021
Q3 | $1.21M | Buy |
8,868
+172
| +2% | +$23.5K | 0.04% | 349 |
|
|
2021
Q2 | $928K | Buy |
8,696
+6,168
| +244% | +$658K | 0.03% | 424 |
|
|
2021
Q1 | $227K | Sell |
2,528
-20
| -0.8% | -$1.8K | 0.01% | 970 |
|
|
2020
Q4 | $235K | Buy |
2,548
+48
| +2% | +$4.43K | 0.01% | 878 |
|
|
2020
Q3 | $257K | Sell |
2,500
-112
| -4% | -$11.5K | 0.01% | 765 |
|
|
2020
Q2 | $264K | Buy |
+2,612
| New | +$264K | 0.01% | 722 |
|
|
2017
Q1 | – | Sell |
-13,644
| Closed | -$203K | – | 714 |
|
|
2016
Q4 | $203K | Buy |
+13,644
| New | +$203K | 0.02% | 637 |
|